Possible treatments for SARS-CoV-2 infection: What do we know?
References
1. Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak-and update on the status. Military Med Research. [internet] 2020 March 16 [cited 1 April 2020];7:11. Available from: http://www.dx.doi.org/10.1186/s40779-020-00240-0
2. Gao J, Tian Z, Yang X. Breakthrough:chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends [internet] 2020 Feb 19 [cited 1 April 2020]. Available from: http://www.dx.doi.org/10.5582/bst.2020.01047
3. Ko WC, Rolain JM, Lee NY, Chen PL, Huang CT, Lee PI, et al. Arguments in favour of remdesivir for treating SARS/CoV/2 infections. Int J Antimicrob Agents. [internet] 2020 March 16 [cited 1 April 2020]. Available from: http://www.dx.doi.org/10.1016/j.ijantimicag.2020.105933
4. Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, et al. First case of 2019 novel coronavirus in the United States. New Engl J Med. [internet] 2020 Jan 31 [cited 1 April 2020]. Available from: http://www.dx.doi.org/10.1056/NEJMoa2001191
5. Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19. New Engl J Med. [internet] 2020 March 18 [cited 1 April 2020]. Available from: http://www.dx.doi.org/10.1056/NEJMoa2001282
2. Gao J, Tian Z, Yang X. Breakthrough:chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends [internet] 2020 Feb 19 [cited 1 April 2020]. Available from: http://www.dx.doi.org/10.5582/bst.2020.01047
3. Ko WC, Rolain JM, Lee NY, Chen PL, Huang CT, Lee PI, et al. Arguments in favour of remdesivir for treating SARS/CoV/2 infections. Int J Antimicrob Agents. [internet] 2020 March 16 [cited 1 April 2020]. Available from: http://www.dx.doi.org/10.1016/j.ijantimicag.2020.105933
4. Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, et al. First case of 2019 novel coronavirus in the United States. New Engl J Med. [internet] 2020 Jan 31 [cited 1 April 2020]. Available from: http://www.dx.doi.org/10.1056/NEJMoa2001191
5. Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19. New Engl J Med. [internet] 2020 March 18 [cited 1 April 2020]. Available from: http://www.dx.doi.org/10.1056/NEJMoa2001282
Downloads
Published
2020-05-14
How to Cite
1.
Soriano Lorenzo JL, Rojas Argüelles P. Possible treatments for SARS-CoV-2 infection: What do we know?. Rev 16 de abril [Internet]. 2020 May 14 [cited 2025 Jan. 31];59(277):e911. Available from: https://rev16deabril.sld.cu/index.php/16_04/article/view/911
Issue
Section
Letter to the Editor
License
Those authors who have publications with this journal, accept the following terms:
The authors will retain their copyright and guarantee the journal the right of first publication of your work, which will be under a Creative license Commons Attribution-NonCommercial-ShareAlike 4.0 International . (CC BY-NC-SA 4.0).
The authors may adopt other non-exclusive license agreements for the distribution of the published version of the work (eg:deposit it in an institutional telemat
